Patent · US Active

Prostaglandin EP4 antagonists

US7612082B2 · kind B2 · utility

0Cited by
6References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2004
Grant dateNov 3, 2009
Priority date
Expiry dateAug 8, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions related to compound 1 or compound 2or pharmaceutically acceptable salts, or prodrugs thereof, which are antagonists of a prostaglandin EP4 receptor, or are prostaglandin EP4 antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.